Trevena, Inc. (TRVN): PT Raised News

TRVN – H.C. Wainwright & Co. raises PT to $7. Stock price at the time of this analyst call was $1.88.


Update: As of Mar. 26, 2019, this bullish analyst call has returned -14.89%.


Key Facts Surrounding This News Item


  • TRVN had a POWR Rating of D (Sell) coming into today.
  • TRVN was 3.81% above its 10-Day Moving Average coming into today.
  • TRVN was 8.56% above its 20-Day Moving Average coming into today.
  • TRVN was 8.61% above its 50-Day Moving Average coming into today.
  • TRVN was 11.99% above its 100-Day Moving Average coming into today.
  • TRVN was -10.42% below its 200-Day Moving Average coming into today.
  • TRVN had returned +17.50% year-to-date leading up to today’s news, versus a 0.00% return from the benchmark S&P 500 during the same period.

More Info About Trevena, Inc. (TRVN)


Trevena Inc. is a clinical stage biopharmaceutical company focused on the discovery, development, and intent to commercialize therapeutics for G protein coupled receptors. The company was founded in 2007 and is based in King of Prussia, Pennsylvania. View our full TRVN ticker page with ratings, news, and more.

TRVN at a Glance

TRVN Current POWR Rating™
Overall POWR Rating™
TRVN Current Price $1.60 0.00%
More TRVN Ratings, Data, and News

TRVN Price Reaction

The day of this event (Mar. 8, 2018)
TRVN Closing Price$2.06 9.57%
TRVN Volume1,454,700
97.73% from avg
Leading up to this event
TRVN 1-mo return24.50%
After this event
TRVN 1-day return5.05%
TRVN 3-day return2.08%
TRVN 5-day return0.00%

TRVN Price Chart



More Trevena, Inc. (TRVN) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All TRVN News
Page generated in 0.9166 seconds.